Fifth Third Bancorp’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Fifth Third Bancorp’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,000	Closed	-$1K	–	2402
2018 Q4	$1K	Hold	2,000	–	–	﹤0.01%	2207
2018 Q3	$3K	Hold	2,000	–	–	﹤0.01%	2076
2018 Q2	$3K	Hold	2,000	–	–	﹤0.01%	2160
2018 Q1	$3K	Hold	2,000	–	–	﹤0.01%	2165
2017 Q4	$5K	Sell	2,000 -829	-29%	-$2.1K	﹤0.01%	2022
2017 Q3	$10K	Buy	2,829 +2,000	+241%	+$6.73K	﹤0.01%	1786
2017 Q2	$3K	Hold	829	–	–	﹤0.01%	2027
2017 Q1	$3K	Hold	829	–	–	﹤0.01%	1968
2016 Q4	$4K	Hold	829	–	–	﹤0.01%	1986
2016 Q3	$4K	Hold	829	–	–	﹤0.01%	2036
2016 Q2	$2K	Hold	829	–	–	﹤0.01%	2159
2016 Q1	$4K	Hold	829	–	–	﹤0.01%	2089
2015 Q4	$3K	Hold	829	–	–	﹤0.01%	2439
2015 Q3	$3K	Hold	829	–	–	﹤0.01%	2567
2015 Q2	$4K	Hold	829	–	–	﹤0.01%	2414
2015 Q1	$6K	Hold	829	–	–	﹤0.01%	2203
2014 Q4	$3K	Buy	+829	New	+$3.34K	﹤0.01%	2217

Fifth Third Bancorp's AST Position: Q1 2019 in Review

Fifth Third Bancorp sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 2,000 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in AST in Q4 2014 and held it in 17 quarters. The position peaked at $10K in Q3 2017. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

Fifth Third Bancorp reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
Fifth Third Bancorp sold 2,000 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $1K.
Fifth Third Bancorp first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 17 quarters.
Fifth Third Bancorp's Asterias Biotherapeutics Inc. Series A position peaked at $10K in Q3 2017.
0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Fifth Third Bancorp's 13F filing for Q1 2019, filed 14 May 2019.